Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederveradermics.com
Veradermics Newsroom
Get the latest updates from Veradermics Newsroom directly as they happen.
Follow now < 10 followers
Latest posts
Last updated 10 months ago
December 11, 2024
10 months ago
December 11, 2024Veradermics Raises $75 Million in Series B Financing and Initiates...
November 29, 2023
10 months ago
November 29, 2023Veradermics CEO Reid Waldman is selected as a Forbes 30...
November 7, 2023
10 months ago
November 7, 2023Veradermics Doses First Patient in a First-in-Human Clinical Trial for...
Veradermics CEO Reid Waldman is selected as a Forbes 30 Under 30 for 2024
12 months ago
Veradermics CEO Reid Waldman is selected as a Forbes 30 Under 30...
Veradermics Inc. Secures Licensing of First-in-Class Antiviral Targeting the Treatment of Molluscum Contagiosum and other Poxviruses
12 months ago
Veradermics Inc. Secures Licensing of First-in-Class Antiviral Targeting the Treatment of Molluscum...
This Startup Raised $20.7 Million To Develop A Kid-Friendly Wart Treatment
12 months ago
ForbesThis Startup Raised $20.7 Million To Develop A Kid-Friendly Wart TreatmentRead All
Why Are We Still Killing Warts the Way We Did in the 1950s? Rethinking a pesky condition.
12 months ago
SlateWhy Are We Still Killing Warts the Way We Did in the...
Kansas City dermatologist launches startup to address common childhood ailment
12 months ago
Business JournalKansas City dermatologist launches startup to address common childhood ailmentRead All
Veradermics Doses First Patient in a First-in-Human Clinical Trial for VDPHL for the Treatment of Pattern Hair Loss (Androgenetic Alopecia)
12 months ago
November 7, 2023Veradermics Doses First Patient in a First-in-Human Clinical Trial for...
Veradermics Doses First Patient in Phase 2 Clinical Trial for VDMN for the Treatment of Common Warts
12 months ago
March 24, 2023Veradermics Doses First Patient in Phase 2 Clinical Trial for...